Keyword: Paratek Pharmaceuticals

40. Nuzyra

Paratek’s omadacycline sailed through phase 3 before winning an FDA green light for two types of infection: community-acquired bacterial pneumoni and acute bacterial skin and skin structure infections.

39. Seysara

Seysara is an oral, once-daily, narrow-spectrum antibiotic derived from tetracycline for people over 9 years old with acne vulgaris.